TABLE 2

Three-Compartment, 2-Tissue Model with 3 Parameter Estimates, k1–k3, Influx Rate Constant K, and Distribution Volume Vd

TypePrimary CancerRecurrent cancerPBPH
n10102
k10.419 ± 0.1360.208 ± 0.073<0.0010.339 ± 0.050
k20.218 ± 0.0740.202 ± 0.124NS0.122 ± 0.066
k30.120 ± 0.0260.140 ± 0.054NS0.066 ± 0.058
K0.152 ± 0.0510.086 ± 0.017<0.010.110 ± 0.049
Vd1.25 ± 0.320.69 ± 0.27<0.0012.19 ± 1.18
Patlak K0.137 ± 0.0620.079 ± 0.0350.020.121 ± 0.048
Patlak Vd1.95 ± 1.671.00 ± 1.27NS2.49 ± 1.22
SUV-early3.80 ± 0.991.83 ± 0.40<0.0013.55 ± 0.60
SUV-late3.84 ± 1.071.91 ± 0.34<0.0013.35 ± 0.24
  • NS = not significant.

  • Patlak plot results are given, as well. Results are expressed as mean ± 1 SD for 3 different tissue types. 1-11C-Acetate uptake at early (6–10 min) and late (15–20 min) time points is presented in SUVs. P denotes significance level by comparison of primary vs. recurrent cancers.